A Chinese company with Chinese leadership - Avis employé Employé (anonyme) BeOne

2,0
25 juin 2023
Employé (anonyme)
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Good pipeline, work from R&D is solid, CEO knows his stuff

Inconvénients

All R&D decisions come from China, they aim to be a global company but it's only in appearance. Working hours suck, the 12-15 hrs difference with China are impossible for a good work-life balance

Découvrez plus d’avis sur BeOne

5,0
24 avr. 2026
Employé (anonyme)
Recommande
Approbation du PDG
Perspective commerciale

Avantages

BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.

Inconvénients

Fast timelines and global expansion may translate into heavy workload and urgency

3,0
9 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Opportunity for professional development, many projects.

Inconvénients

WLB, no transparency, no promotion Ex-China, hidden layoffs

Voir les avis par: Utile|Évaluation|Date|Tout